Spinal Degenerative Disease Concomitant Sacro-Iliac and Lumbosacral Spinal Fusion

Overview

About this study

The purpose of this study is to validate the clinical effectiveness of an FDA-cleared, Mayo innovated Sacroiliac Joint Fusion (SIJF) device in the setting of long-segment Lumbosacral Spinal Fusion (LSF).

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18-80 at the time of surgery.
  • Male or female.
  • Indicated for long-segment LSF:
    • Long segment in this study will be defined as UIV of L2 or higher with extension to the sacrum;
    • Indication will be determined by the treating surgeon, which may include but is not limited to: degenerative disease, deformity, neurogenic claudication, radiculopathy, instability, or trauma.
  • Symptomatic SI disease, radiographic SI degenerative disease, or need for prophylactic/supplemental lumbopelvic fixation as determined by the treating surgeon.

Exclusion Criteria:

  • Failure to meet inclusion criteria.
  • Prior long-segment LSF extending to the sacrum/pelvis.
  • Prior SIJF.
  • Revision SIFJ.
  • Age less than 18 or greater than 80.
  • Patients who are pregnant, breast feeding, or plan to become pregnant in the next 3 years. Please reference section 1.5.
  • Vulnerable patient (ie patient unable to provide their own consent, dementia, intellectual disability/delay).
  • Patients who do not clear pre-operative medical examination.
  • Pregnancy which prevents surgical intervention or during the follow-up period which prevents safe acquisition of radiographic follow-up.
  • Patients who, either preoperatively or intraoperatively it is determined that the investigational device may not be safely placed due to anatomic or extraneous factors.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/20/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Arjun Sebastian, M.D.

Open for enrollment

Contact information:

Cassandra Willson

(507) 293-9234

Kingsbury.Cassandra@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20563667

Mayo Clinic Footer